| 0.8 0.34 (73.91%) | 08-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.31 |
1-year : | 1.54 |
| Resists | First : | 1.12 |
Second : | 1.31 |
| Pivot price | 0.49 |
|||
| Supports | First : | 0.65 |
Second : | 0.36 |
| MAs | MA(5) : | 0.48 |
MA(20) : | 0.51 |
| MA(100) : | 0.89 |
MA(250) : | 1.08 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 35.2 |
D(3) : | 18.6 |
| RSI | RSI(14): 70.4 |
|||
| 52-week | High : | 2.58 | Low : | 0.36 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ADGM ] has closed Bollinger Bands are 18.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.13 - 1.14 | 1.14 - 1.14 |
| Low: | 0.54 - 0.55 | 0.55 - 0.55 |
| Close: | 0.8 - 0.81 | 0.81 - 0.82 |
Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.
Tue, 04 Aug 2026
These stocks are making the most noise in today's session. - ChartMill
Tue, 04 Aug 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Tue, 04 Aug 2026
ADGM stock surges as investors react to next-generation ULTA milestone - Quiver Quantitative
Tue, 04 Aug 2026
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours - Benzinga
Mon, 03 Aug 2026
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 22 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 70.5 (%) |
| Shares Short | 63 (K) |
| Shares Short P.Month | 70 (K) |
| EPS | -1.33 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.25 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -30.6 % |
| Return on Equity (ttm) | -268.9 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -0.02 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -16 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.62 |
| PEG Ratio | 0 |
| Price to Book value | 3.11 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.13 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|